Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Rachna T, Shroff"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Biliary tract cancer (BTC) includes intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma, gallbladder cancer, and ampulla of Vater cancer (AVC). Although BTC is rare in the US, incidence is increasing and elevate
Externí odkaz:
https://doaj.org/article/e1bd953cc4b3429fa9885ccc59e9867e
Autor:
Jane E. Rogers, Jonathan D. Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T. Shroff, Robert Wolff, Gauri R. Varadhachary, Milind M. Javle, Michael Overman, David R. Fogelman, Kanwal P. S. Raghav, Shubham Pant, Florencia McAllister
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5406-5415 (2020)
Abstract Background Gemcitabine (GEM) plus nab‐paclitaxel (NabP) (GEM 1000 mg/m2 IV over 30 minutes + NabP 125 mg/m2 IV given days 1, 8, and 15 every 28 days) is one of the two standard of care combination therapies for metastatic pancreatic ductal
Externí odkaz:
https://doaj.org/article/661f185a502f41a69c6a00dc6f1e1360
Autor:
Rachna T. Shroff, Karyn A. Goodman, Janice M. Mehnert, Julie M. Vose, Susan E. Moran, Jennifer L. Yessaian, Lance Baldo, Brian M. Alexander, Quita B. Highsmith, Jennifer M. Mills, Pamela L. Kunz
Publikováno v:
Journal of Clinical Oncology. 41:1659-1663
Autor:
Reham Abdel-Wahab, Gauri R. Varadhachary, Priya R. Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background Binding of insulin-like growth factor-I (IGF-1) to its receptor (IGF-1R) initiates downstream signals that activate PI3K/Akt/mTOR and MEK/Erk pathways, which stimulate cancer cell proliferation and induce drug resistance. Cross ta
Externí odkaz:
https://doaj.org/article/5933a3fa7ece44658f4f1497a1a3ecd6
Autor:
Malvi, Savani, Rachna T, Shroff
Publikováno v:
Hematology/Oncology Clinics of North America. 36:961-978
Pancreatic cancer is a fatal malignancy that is projected to emerge as the second leading cause of cancer-related death in the United States. Despite the critical advances in surgical strategies, radiographic techniques, and systemic therapy, the tre
Publikováno v:
Hepatobiliary Surgery and Nutrition. 11:555-566
Cholangiocarcinomas (CCA) are a group of rare cancers with an incidence of about 1.26 per 100,000 people. The disease reflects one of three different subtypes: intrahepatic, perihilar or hilar and distal cholangiocarcinoma. The preferred modality of
Autor:
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osama E Rahma, Jennifer Stanton, Thomas T DeLeon, Marc Roth, Mary Linton B Peters, Andrew X Zhu, Jochen K Lennerz, A John Iafrate, Kylie Boyhen, Christine VanCott, Lewis R Roberts, Stacie Lindsey, Nora Horick, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Robin Kate Kelley, Milind M Javle, Lipika Goyal
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background Treatment patterns for intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) differ, but limited studies exist comparing them. This study examines differences in molecular profiling rates and treatment patterns in
Autor:
Jason B. Fleming, Eric P. Tamm, Priya Bhosale, Huamin Wang, Matthew H. Katz, Christopher H. Crane, Michael P. Kim, Cullen M. Taniguchi, Anirban Maitra, Mauro Ferrari, Jeffrey E. Lee, Prajnan Das, Rachna T. Shroff, Gauri R. Varadhachary, Milind Javle, Robert A. Wolff, Newsha Nikzad, Mohamed Zaid, Anil Chauhan, Shun Yu, Kim A. Reiss, Naveen Garg, Dali Li, Mayrim V. Rios Perez, Peter C. Park, Huaming Yan, Deyali Chatterjee, Ahmed M. Amer, Muayad Almahariq, Dalia Elganainy, Rong Ye, Brian P. Hobbs, F. Anthony San Lucas, Ya'an Kang, John S. Lowengrub, Vittorio Cristini, Yeonju Lee, Eugene J. Koay
Mathematical model simulation of low delta tumor growth (lambda = 0.2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2e4d4c75428a8e88a03b86c7328f4b
https://doi.org/10.1158/1078-0432.22470222
https://doi.org/10.1158/1078-0432.22470222
Autor:
Jason B. Fleming, Eric P. Tamm, Priya Bhosale, Huamin Wang, Matthew H. Katz, Christopher H. Crane, Michael P. Kim, Cullen M. Taniguchi, Anirban Maitra, Mauro Ferrari, Jeffrey E. Lee, Prajnan Das, Rachna T. Shroff, Gauri R. Varadhachary, Milind Javle, Robert A. Wolff, Newsha Nikzad, Mohamed Zaid, Anil Chauhan, Shun Yu, Kim A. Reiss, Naveen Garg, Dali Li, Mayrim V. Rios Perez, Peter C. Park, Huaming Yan, Deyali Chatterjee, Ahmed M. Amer, Muayad Almahariq, Dalia Elganainy, Rong Ye, Brian P. Hobbs, F. Anthony San Lucas, Ya'an Kang, John S. Lowengrub, Vittorio Cristini, Yeonju Lee, Eugene J. Koay
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with variable presentations and natural histories of disease. We hypothesized that different morphologic characteristics of PDAC tumors on diagnostic computed tomography (CT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17436dcd95dd058b959d9246f6e4f134
https://doi.org/10.1158/1078-0432.c.6527469.v1
https://doi.org/10.1158/1078-0432.c.6527469.v1
Autor:
Milind Javle, Robert A. Wolff, Shubham Pant, Kanwal Raghav, Ahmed Shalaby, Kavitha Reddy, Priya Bhosale, Anaemy Danner De Armas, Lianchun Xiao, Shalini Makawita, Rachna T. Shroff, Sunyoung Lee
Supplementary Figure from Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3a5df53829e8987ae7943e68d4a786
https://doi.org/10.1158/1078-0432.22487568.v1
https://doi.org/10.1158/1078-0432.22487568.v1